Cell Signaling Technology

TNK1 (C44F9) Rabbit Monoclonal Antibody

#4570 · $158

100
Citing papers
8.3k
Combined citations
Supplier page Find this product

Research areas

Lung Cancer Treatments and Mutations11FOXO transcription factor regulation8Ubiquitin and proteasome pathways7interferon and immune responses7Protein Degradation and Inhibitors6Immune Response and Inflammation6Lung Cancer Research Studies6Cancer, Hypoxia, and Metabolism5

Papers citing this product

1
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Cell·2020·366 cit.·DOI
2
Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment
Oncotarget·2016·272 cit.·DOI
3
Recent Advances in Targeting ROS1 in Lung Cancer
Journal of Thoracic Oncology·2017·259 cit.·DOI
4
Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
Nature Communications·2017·238 cit.·DOI
5
Testing for ROS1 in non-small cell lung cancer: a review with recommendations
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2016·220 cit.·DOI
6
The Dictyostelium Kinome—Analysis of the Protein Kinases from a Simple Model Organism
PLoS Genetics·2006·187 cit.·DOI
7
Endosomal signalling via exosome surface TGFβ‐1
Journal of Extracellular Vesicles·2019·179 cit.·DOI
8
Epidermal Growth Factor Receptor Exposed to Oxidative Stress Undergoes Src- and Caveolin-1-dependent Perinuclear Trafficking
Journal of Biological Chemistry·2006·167 cit.·DOI
9
Selective Activation of Microglia Facilitates Synaptic Strength
Journal of Neuroscience·2015·167 cit.·DOI
10
Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
Modern Pathology·2013·154 cit.·DOI